Surpass-3, Type 2 Diabetes Research

Enroll Now

Type of Study:

Type 2 diabetes patients who are 18 years and older

Title of Study:

Open-Label Trial Comparing the Effect of (weekly) LY3298176 Versus (daily) Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes

Short Title:


Study Length: 59 Weeks

Target Age/Sex: 18 years and older, Male and Female


Participants will receive at no cost: study product, study materials and study-specific procedures


Live better, healthier, smarter

Schedule an Appointment